Decision Aid to Facilitate Shared Decision Making During Treatment in Schizophrenia

Inclusion Criteria: * Patients with diagnosis of Schizophrenia or Schizoaffective Disorder as per by their medical record diagnosis. * Patients currently on olanzapine therapy and BMI \>29.9. * Patients treated with olanzapine for greater than or equal to 3 months prior to enrollment. * Patient would be required to have either attempted dietary, lifestyles modifications and/or participated in weight loss programs. * Patients with no history of psychiatric hospitalizations in past six months and judged by treating clinician to be suitable for antipsychotic medication switch. * Patients with adequate decisional capacity to make a choice about participating in this research study. * Patients, who are able to comprehend and satisfactorily comply with protocol requirements and have an ability to read and write English. * Patients, who signed the written consent given prior to entering any study procedure. Exclusion Criteria: * Patients with a history of treatment resistant schizophrenia or past trials with clozapine. * Patients with a concurrent DSM-IV diagnosis of PTSD as per their medical record. * Substance Dependence or Abuse (excluding nicotine) within one month prior to the screening visit. * Patients with a history of non-response, intolerance or hypersensitivity ot perphenazine. * Subjects with history of treatment of clozapine. * Patients who based on history of mental status examination have a significant risk of committing suicide. * Patients who are homicidal or violent and who are in the Investigator's opinion in significant imminent risk of hurting others. * Female patients who are pregnant, planning to become pregnant, or if of childbearing potential, not using an acceptable method of birth control. * Patient currently receiving depot neuroleptics. * Patients with visual impairments.